Bionik Laboratories Corp.
BNKL · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,946 | -$10,408 | -$13,620 | -$25,016 |
| Dep. & Amort. | $63 | $103 | $190 | $381 |
| Deferred Tax | $0 | $0 | $7,182 | $14,185 |
| Stock-Based Comp. | $377 | $438 | $819 | $1,782 |
| Change in WC | $1,013 | $140 | $399 | -$571 |
| Other Non-Cash | $106 | $5,580 | $406 | $177 |
| Operating Cash Flow | -$3,387 | -$4,147 | -$4,624 | -$9,064 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$13 | $0 | -$160 |
| Net Acquisitions | -$215 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$224 | -$13 | $0 | -$160 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,050 | $5,550 | $2,962 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $11,046 |
| Financing Cash Flow | $2,050 | $5,550 | $2,962 | $11,046 |
| Forex Effect | -$3 | -$7 | $0 | $0 |
| Net Chg. in Cash | -$1,564 | $1,383 | -$1,661 | $1,823 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,991 | $608 | $2,270 | $447 |
| End Cash | $427 | $1,991 | $608 | $2,270 |
| Free Cash Flow | -$3,387 | -$4,160 | -$4,624 | -$9,223 |